Programs & Projects

Zagaya was established in 2011 to ensure access to affordable malaria treatments in the developing world. Zagaya licenses technologies that allow it to partner and collaborate to solve problems. Over the longer term, Zagaya is committed to ensuring artemisinin-based combination therapies (ACTs) remain affordable by reducing the cost of raw materials, manufacturing, formulation with co-drugs, packaging and distribution. Student intern Pallavi Suresh developed a detailed analysis and strategy for antimalarial supply chains.